Process plagued by missing efficacy data and questionable evidence; Some experts argue that FDA’s standards for evidence are too low. Since the US Food and Drug Administration (FDA) established its accelerated approval pathway for drugs in 1992, nearly half (112) of the 253 drugs authorized have not been confirmed as […]